C.M. Bidwell & Associates’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $876 | Hold |
18
| – | – | ﹤0.01% | 391 |
|
|
2025
Q1 | $613 | Hold |
18
| – | – | ﹤0.01% | 399 |
|
|
2024
Q4 | $708 | Sell |
18
-38
| -68% | -$1.5K | ﹤0.01% | 440 |
|
|
2024
Q3 | $2.63K | Sell |
56
-736
| -93% | -$34.6K | ﹤0.01% | 422 |
|
|
2024
Q2 | $42.8K | Hold |
792
| – | – | 0.03% | 234 |
|
|
2024
Q1 | $54K | Sell |
792
-10
| -1% | -$682 | 0.04% | 221 |
|
|
2023
Q4 | $50.2K | Sell |
802
-2,317
| -74% | -$145K | 0.04% | 217 |
|
|
2023
Q3 | $142K | Buy |
3,119
+695
| +29% | +$31.5K | 0.11% | 162 |
|
|
2023
Q2 | $136K | Buy |
2,424
+724
| +43% | +$40.6K | 0.1% | 181 |
|
|
2023
Q1 | $76.9K | Buy |
1,700
+1,644
| +2,936% | +$74.4K | 0.06% | 259 |
|
|
2022
Q4 | $2.28K | Buy |
56
+38
| +211% | +$1.54K | ﹤0.01% | 436 |
|
|
2022
Q3 | $1K | Sell |
18
-35
| -66% | -$1.94K | ﹤0.01% | 448 |
|
|
2022
Q2 | $3K | Hold |
53
| – | – | ﹤0.01% | 406 |
|
|
2022
Q1 | $3K | Buy |
53
+28
| +112% | +$1.59K | ﹤0.01% | 438 |
|
|
2021
Q4 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 515 |
|